STOCK TITAN

LifeMD (LFMD) director granted 50,000 restricted shares and 35,000 RSUs

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Simon Roberto reported acquisition or exercise transactions in this Form 4 filing.

LifeMD, Inc. reported that director Simon Roberto received two equity awards of common stock. On May 4, 2026, he was granted 50,000 restricted shares that vested immediately. On August 11, 2026, he received 35,000 restricted stock units that are scheduled to vest on June 1, 2027.

Positive

  • None.

Negative

  • None.
Insider Simon Roberto
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F2 35,000 $0.00 $0.00
Grant/Award Common Stock F1 50,000 $0.00 $0.00
Holdings After Transaction: Common Stock — 288,175 shares (Direct)
Footnotes (2)
  1. F1. The grant of restricted shares vests immediately.
  2. F2. Restricted stock units that vest on June 1, 2027.
Restricted share grant 50,000 shares Grant of restricted shares to director on May 4, 2026; vests immediately
RSU grant 35,000 units Restricted stock units granted on August 11, 2026; vest on June 1, 2027
Per-share grant price $0.0000 per share Reported price per share for both equity award transactions
Acquisition transactions 2 transactions Both reported entries classified as grant, award, or other acquisition (code A)
restricted shares financial
"The grant of restricted shares vests immediately."
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
Restricted stock units financial
"Restricted stock units that vest on June 1, 2027."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition"

FAQ

What insider transactions did LifeMD (LFMD) disclose for Simon Roberto?

LifeMD disclosed that director Simon Roberto received two equity awards: 50,000 restricted shares granted on May 4, 2026, and 35,000 restricted stock units granted on August 11, 2026, vesting June 1, 2027.

How many LifeMD (LFMD) shares were granted to Simon Roberto on May 4, 2026?

On May 4, 2026, Roberto was granted 50,000 shares of common stock as restricted shares. A related footnote states that this grant of restricted shares vests immediately, indicating no waiting period for vesting.

What are the vesting terms of Simon Roberto’s August 11, 2026 LifeMD (LFMD) award?

The August 11, 2026 award consists of 35,000 restricted stock units. A footnote specifies that these restricted stock units vest on June 1, 2027, creating a defined future vesting date for this grant.

Were Simon Roberto’s LifeMD (LFMD) equity awards purchases or grants?

Both reported transactions are grants or awards, not market purchases. The Form 4 classifies each as a grant, award, or other acquisition of common stock, with a reported price per share of $0.0000 for each award.

Does the Form 4 indicate any sales of LifeMD (LFMD) stock by Simon Roberto?

No sales are indicated. The transaction summary shows two acquisition transactions and no sales or dispositions. Both entries are coded as grants (transaction code A) of common stock or related restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Simon Roberto

(Last)(First)(Middle)
C/O LIFEMD, INC.
236 FIFTH AVENUE, 4TH FLOOR

(Street)
NEW YORK NEW YORK 10001

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/04/2026A50,000(1)A$0253,175D
Common Stock08/11/2026A35,000(2)A$0288,175D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The grant of restricted shares vests immediately.
2. Restricted stock units that vest on June 1, 2027.
/s/ Roberto Simon08/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)